Publication

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…

Certara2026 年 1 月 22 日

On-Demand Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…

Certara2026 年 1 月 22 日

Blog

肿瘤精准剂量革命：Project Optimus下的适应性临床试验新范式

Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…

Certara2026 年 1 月 16 日

Webinar

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Certara2026 年 1 月 14 日

Conference

Longwood Healthcare Leaders

Certara2026 年 1 月 8 日

Publication

填补空白：Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development

Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of…

Certara2026 年 1 月 7 日

Blog

按时交付：Why pharmacometrics (pmx) is the anchor of successful regulatory submissions

Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…

Certara2025 年 12 月 29 日

Fact Sheet

Strategic Project Management for Accelerated Drug Development

Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…

Certara2025 年 12 月 23 日

Press Coverage

Pharma positions itself for 2026 amid an evolving US landscape

Explore how U.S. policy changes — including tariffs, onshoring, and Most Favored Nation pricing —…

Certara2025 年 12 月 22 日

Publication

A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection

This study synthesizes data from a large body of clinical trials to evaluate rates of…

Certara2025 年 12 月 18 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

肿瘤精准剂量革命：Project Optimus下的适应性临床试验新范式

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Longwood Healthcare Leaders

填补空白：Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development

按时交付：Why pharmacometrics (pmx) is the anchor of successful regulatory submissions

Strategic Project Management for Accelerated Drug Development

Pharma positions itself for 2026 amid an evolving US landscape

A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection

订阅时事通讯

快捷链接

解决方案

联系我们